BBIO
#700
BridgeBio Pharma, Inc. - Common Stock
78.6 8 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.87%
Monthly Change
-7.02%
6 month change
+22.25%
Year Change
+38.04%
Previous Close
79.3 7
Open
78.6 8
Low
78.6 8
High
78.6 8
Volume
121
Financials
- Market Capitalization 15.38 B
- Employee 839
- Founded 2015
- CEO Neil Kumar
- Website www.bridgebio.com
- Headquarter Delaware, United States
- FIGI BBG00P9KDZK6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-20.24
Price to sales ratio
29.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 675 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 251.10 USD | +0.73% | +0.94% | -2.39% | +79.36% | 16.30 B USD | ||
| 696 |  ASND Ascendis Pharma A/S - American Depositary Shares | 249.36 USD | -0.36% | -2.48% | -2.19% | +21.59% | 15.45 B USD | ||
| 757 |  EXEL Exelixis, Inc. - Common Stock | 55.26 USD | -1.50% | +2.83% | -2.11% | +41.55% | 13.69 B USD | ||
| 802 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 65.29 USD | -0.49% | -3.35% | +5.19% | +13.47% | 12.64 B USD |
Frequently asked questions about BridgeBio Pharma, Inc. Common Stock
What is the BridgeBio Pharma, Inc. Common Stock stock price today?
The current price of BridgeBio Pharma, Inc. Common Stock (BBIO) is 78.68. Over the past 24 hours, the stock has changed by -0.87%. Follow the BBIO chart for real-time price dynamics.
What is the stock ticker of BridgeBio Pharma, Inc. Common Stock?
BridgeBio Pharma, Inc. Common Stock trades under the ticker BBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BridgeBio Pharma, Inc. Common Stock stock going up?
BBIO has changed by -5.08% over the last week, -7.02% over the last month, and +38.04% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of BridgeBio Pharma, Inc. Common Stock?
BridgeBio Pharma, Inc. Common Stock currently has a market capitalization of 15.38 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were BridgeBio Pharma, Inc. Common Stock earnings last quarter?
Last quarter, BridgeBio Pharma, Inc. Common Stock reported earnings of -0.78 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was BridgeBio Pharma, Inc. Common Stock revenue for the last quarter?
BridgeBio Pharma, Inc. Common Stock reported quarterly revenue of 243.68 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was BridgeBio Pharma, Inc. Common Stock net income for the last quarter?
BridgeBio Pharma, Inc. Common Stock reported net income of -155.89 M for the last quarter. The previous quarter showed -166.56 M, which means net income changed by +6.40%.
How many employees does BridgeBio Pharma, Inc. Common Stock have?
As of the latest available data, BridgeBio Pharma, Inc. Common Stock has 839 employees. Workforce size can provide additional context about the company's scale and operations.
What is BridgeBio Pharma, Inc. Common Stock EBITDA?
BridgeBio Pharma, Inc. Common Stock EBITDA is -106.03 M, and its EBITDA margin is -43.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BridgeBio Pharma, Inc. Common Stock stock?
You can buy BridgeBio Pharma, Inc. Common Stock (BBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BridgeBio Pharma, Inc. Common Stock stock?
Investing in BridgeBio Pharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BBIO chart and related analysis on metatrader.com as part of your research.